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Research on the human microbiome has established
that commensal and pathogenic bacteria can influ-
ence obesity, cancer, and autoimmunity through
mechanisms mostly unknown. We found that a
component of bacterial biofilms, the amyloid protein
curli, irreversibly formed fibers with bacterial DNA
during biofilm formation. This interaction accelerated
amyloid polymerization and created potent immuno-
genic complexes that activated immune cells,
including dendritic cells, to produce cytokines such
as type I interferons, which are pathogenic in sys-
temic lupus erythematosus (SLE). When given sys-
temically, curli-DNA composites triggered immune
activation and production of autoantibodies in
lupus-prone and wild-type mice. We also found that
the infection of lupus-prone mice with curli-produc-
ing bacteria triggered higher autoantibody titers
compared to curli-deficient bacteria. These data pro-
vide a mechanism by which the microbiome and
biofilm-producing enteric infections may contribute
to the progression of SLE and point to a potential mo-
lecular target for treatment of autoimmunity.
INTRODUCTION
Systemic lupus erythematosus (SLE) is a complex autoimmune
disease in which both genetic and environmental triggers
contribute to disease onset and to the production of autoanti-
bodies to double stranded DNA (dsDNA) and nuclear proteins
(Elkon and Stone, 2011; Morel, 2010; Moser et al., 2009). Infec-
tion is an important environmental trigger for lupus flares and a
major cause of morbidity and mortality in SLE patients (Petri,
1998). In fact, 20%–55% of deaths in SLE patients are attribut-
able to infections and up to 23% of hospitalizations are due to
infectious complications (Barrera-Vargas et al., 2014; Fessler,
2002). Bloodstream infections, urinary tract infections, soft tis-
sue infections, and pneumonia are common in SLE patients.Frequent Salmonella infections have been reported, especially
those caused by Salmonella enterica serovar Typhimurium and
serovar Enteritidis (Gerona and Navarra, 2009). Moreover,
Salmonella behave more aggressively in SLE patients: instead
of causing localized gastroenteritis, infection may result in
bacteremia or complications in soft tissues with high mortality
rates (Costa-Reis et al., 2013; Lim et al., 2001; Pablos et al.,
1994; Tsao et al., 2002). Although bacterial infections are thought
to contribute to SLE pathogenesis by inducing cell death
and inflammation, the exact mechanisms by which bacteria
contribute to SLE pathogenesis remain unknown.
Biofilms are bacterial communities embedded in an extracel-
lular matrix (ECM), which protects bacteria from environmental
stresses including antibiotics (Lo´pez et al., 2010; O’Toole et al.,
1999). Biofilms are formed on many biotic and abiotic surfaces
including the mucosal surfaces of the human body and
indwelling medical devices. Several infections are associated
with biofilms including UTI, otitis media, and periodontal dis-
eases (Bjarnsholt, 2013), suggesting that the human immune
system is exposed to biofilm components throughout life.
Amyloids are proteins with a conserved b sheet structure.
Mammalian amyloids accumulate in tissues during various debil-
itating human diseases including Alzheimer’s disease (Schnabel,
2010). Several bacterial species actively produce amyloid pro-
teins in biofilms including those of S. Typhimurium and E. coli.
Amyloid fibers of the latter enteric bacteria are termed curli,
which are encoded by the csg gene cluster composed of
csgBAC and csgDEFG operons. Production and polymerization
of bacterial CsgA protein leads to the generation of the bacterial
amyloid curli (Barnhart and Chapman, 2006; Chapman et al.,
2002; Ro¨mling et al., 1998; Wang et al., 2007). Curli fibers are ex-
pressed during various enteric infections including sepsis,
gastroenteritis, and UTI (Bian et al., 2000; Humphries et al.,
2003; Kai-Larsen et al., 2010). We have previously shown that
curli fibers induce immune activation by triggering the Toll-like
receptor (TLR) 2-TLR1 heterocomplex (Rapsinski et al., 2013;
Tu¨kel et al., 2005, 2009, 2010). In addition, many bacterial bio-
films contain extracellular DNA (eDNA), which acts to stabilize
the biofilm matrix (Whitchurch et al., 2002).
A number of reports have suggested that DNA complexedwith
a protein antigen can induce lupus-like disease (Desai et al.,
1993; Lande et al., 2007). Human prototypic amyloidogenicImmunity 42, 1171–1184, June 16, 2015 ª2015 Elsevier Inc. 1171
peptides, prion fragment and amyloid-b 1-42 can directly bind to
DNA (Di Domizio et al., 2012b; Jime´nez, 2010). Immunization
with amyloid fibers complexed with nucleic acids, in the pres-
ence of the classic adjuvant CFA, can induce autoantibodies in
nonautoimmune mice within 12 weeks (Di Domizio et al.,
2012a). Although groundbreaking, the amyloid-DNA composites
used in the latter study were made from human serum albumin
and salmon sperm DNA—an artificial composite to which the
immune system would not normally be exposed. Moreover, the
administration of CFA together with amyloid-DNA makes it un-
clear whether amyloid-DNA complexes are simply autoantigens
or if they may act as adjuvants to stimulate the autoimmune
response. Therefore, we asked whether the natural amyloid
fibers from bacterial biofilms might be bound tightly enough to
biofilm-derived DNA to create immunostimulatory amyloid-
DNA composites and investigated the role of bacterial amy-
loid-DNA composites in lupus pathogenesis and induction of
autoimmunity.
Using a multidisciplinary approach, we found that curli fibers
bound tightly to eDNA in biofilms. Curli-DNA composites were
powerful immune stimulators, acting synergistically to activate
innate and adaptive immunity and triggered autoantibody pro-
duction. Finally, we showed that infection with curli-producing
bacteria accelerated the generation of autoantibodies in lupus-
prone mice, suggesting that infections with amyloid producing
bacteria may be important environmental triggers for the pro-
gression of lupus.
RESULTS
Curli-DNA Composites in S. Typhimurium Biofilms
Curli fibers are conserved among the members of Enterobacter-
iceae family (Barnhart and Chapman, 2006). Here, we studied
the biofilms of S. Typhimurium as a model organism, since
Salmonella is an important cause of infection and morbidity in
SLE patients (Gerona and Navarra, 2009). S. Typhimurium forms
pellicle biofilms at the air–liquid interface similar to E. coli (Hung
et al. 2013). When grown on microscope slides in 50 ml conical
tubes for 72 hr, the biofilm thickness reached up to 33 mm (Fig-
ures 1A and S1A). Under the same experimental conditions,
a csgBA mutant that could not express curli monomers failed
to form a pellicle biofilm, indicating that curli is required for
S. Typhimurium biofilm (Figures S1A and S1B). We monitored
the kinetics of curli expression in the biofilms by flow cytometry
using a S. Typhimurium strain carrying a plasmid in which
PcsgBA promoter drives the expression of green fluorescence
protein (GFP) (PcsgBA::gfp). Curli expression started within 48 hr
after inoculation, as > 70% of the bacteria expressed GFP. By
72 hr, GFP was detected in virtually the entire population of the
biofilm, suggesting that most bacteria express curli (Figure 1B).
We also visualized curli fibers in biofilms by staining the pellicle
with an amyloid specific stain, Congo red (CR) (Figure 1C).
We hypothesized that the nucleic acids found within the bac-
terial biofilms (Johnson et al., 2013; Whitchurch et al., 2002)
could be derived from dying bacteria. To monitor cell death in
the biofilm, we stained the bacteria in the pellicle with a live
(Syto9)/dead (PI) stain. Approximately 10% of the bacteria in
the biofilm were determined dead (Syto9 negative/PI positive)
by 72 hr. Unexpectedly, a large fraction of the population—1172 Immunity 42, 1171–1184, June 16, 2015 ª2015 Elsevier Inc.approximately 57%—showed positivity for both stains, suggest-
ing that these cells were dying. However, this result was puzzling
because the bacterial enumeration did not reveal a decrease in
the bacterial numbers in the pellicle biofilm (Figures 1D and
S1C). To further analyze this phenomenon, we stained the biofilm
of a S. Typhimurium strain carrying the reporter PcsgBA::gfp with
PI to visualize curli expression and DNA release. Green cells
were surrounded by a red corona, demonstrating that eDNA
was localized around live, curli-expressing cells and indicating
that the high percentage of PI positivity in Figure 1D is not due
to cell death. We also observed high DNA staining of channels
within the biofilm (Figures 1E and 1F). Therefore, eDNA, either
released by dying bacteria or actively released into the ECM, is
an important component of the S. Typhimurium biofilm pellicle
(Figure S1D).
We found the amyloid specific dye CR to be incompatible with
nucleic acid dyes PI and DAPI but not with Toto-1. Therefore, we
stained the S. Typhimurium biofilms using CR (red) and Toto-1
(blue) and showed that the amyloids and DNA colocalized
(magenta) within S. Typhimurium biofilms (Figure 2A). Treatment
of S. Typhimurium biofilms with DNase did not reduce the biofilm
mass as dramatically as reported for P. aeruginosa biofilms,
which do not contain amyloids (Whitchurch et al., 2002) (Figures
2B and 2C). Due to the resistance of amyloids to enzymatic
breakdown, we hypothesized that the incorporation of eDNA
into the curli fibers rendered eDNA resistant to DNase. To further
investigate the interactions of curli and eDNA, we purified curli
from S. Typhimurium biofilms (Collinson et al., 1991). It is impor-
tant to note that the purification process of curli includes multiple
cycles of DNase and RNase treatments, boiling in SDS, and
overnight electrophoresis through a preparative SDS polyacryl-
amide gel to eliminate any contaminants. When we stained
such purified curli individually with CR or nucleic acid-specific
dyes, curli stained positive with PI andHoescht 33258, indicating
the presence of nucleic acids in the purified curli fibers (Fig-
ure 2D, center and right panel). Birefringence, a characteristic
of amyloids stained with CR, was visible under polarizing micro-
scopy (Figure 2D, left panel). Purified curli stained positive with
ethidium bromide, a DNA-specific dye, confirming the presence
of DNA in the fibers. Further treatment of purified curli with
DNase or RNase did not remove the nucleic acids from the fibers
unless fibers were broken down into its monomeric units by hex-
aflouroisopropanol (HFIP) and DMSO treatment (Figure S2). Us-
ing phenol-chloroform extraction, we were able to extract an
average of 639 ng (SD = 200) of DNA per 100 mg of purified curli
that had been extensively treated with DNase. Finally, purified
curli was costained with Thioflavin T (ThT), another amyloid-spe-
cific stain, and Hoescht33258. Purified curli fibers stained posi-
tive with both dyes (Figure 2E). Thus, bacterial eDNA is protected
from degradation by its close association with amyloid fibers.
DNA Accelerates the Polymerization of Curli Fibers
Nucleic acids promote the polymerization of a human amyloid
precursor protein (Di Domizio et al., 2012b). Amyloid polymeriza-
tion can be monitored using ThT, and it shows a sigmoidal poly-
merization curve with a lag phase followed by exponential
growth of amyloid fibers, which eventually reaches a plateau
as all monomers are consumed (Naiki et al., 1991). To determine
the effects of DNA on curli polymerization, we utilized a synthetic
Figure 1. Salmonella Biofilms Contain Curli Amyloids and eDNA
(A) 3D projection (upper) and side view (lower) of Confocal Laser ScanningMicroscopy images of GFP expressing S. Typhimurium (green) pellicle biofilms during a
72 hr time course of growth. White bars represent 10 mm.
(B) Curli expression was monitored by flow cytometry (FC) for 72 hr in S. Typhimurium containing a PcsgBA::gfp reporter plasmid.
(C) 3D projection of CLSM images of S. Typhimurium biofilm with PcsgBA::gfp reporter plasmid at 72 hr. Biofilm was stained with CR (red).
(D) FC analysis of cell death in Salmonella biofilms using live/dead staining with Syto 9 and PI.
(E) 3D projection of CLSM images of a 72 Salmonella biofilm with PcsgBA::gfp reporter plasmid stained with PI (pseudocolored blue).
(F) CLSM image of a 72 hr S. Typhimurium biofilm with PcsgBA::gfp reporter plasmid stained with PI. Red ‘‘corona’’ of extracellular DNA around the bacteria is
visible. All data shown are representative samples of three independent experiments.peptide corresponding to the fourth and fifth repeats of the CsgA
monomer of curli (CsgAR4-5), which is devoid of any DNA
contamination, and we performed in vitro polymerization assays
using ThT in the presence or absence of increasing concentra-
tions of the synthetic oligonucleotide, CpG, and of Salmonella
genomic DNA. Addition of DNA accelerated the polymerizationof CsgAR4-5 by decreasing the lag phase of polymerization by
an average 172 min with CpG DNA and 65 min with Salmonella
genomic DNA. We think that the difference in the polymerization
rates is due to the DNA fragment size in each DNA source. Since
bacterial biofilms form in the gastrointestinal tract of humans
(Bollinger et al., 2007; Macfarlane et al., 2011; Macfarlane andImmunity 42, 1171–1184, June 16, 2015 ª2015 Elsevier Inc. 1173
Figure 2. eDNA Forms Complexes with Curli in Biofilms Accelerating the Amyloid Polymerization Process and Limiting Its Degradation by
DNase
(A) CLSM image of GFP expressing S. Typhimurium (green) biofilm grown for 72 hr and stained with CR (red) and TOTO-1 Iodide (blue).
(B) Crystal violet assay of S. Typhimurium biofilms grown in 96-well plates with or without 3 hr DNase treatment. Data shown is average and SE from 5 wells.
Experiments were completed in triplicate.
(C) 3D reconstructions (upper) and side-view (lower) CLSM images of GFP expressing Salmonella biofilms with and without DNase treatment for 3 hr after biofilm
was formed showing minimal change in biofilm thickness after treatment with DNase. White bars on side views represent 10 mm. Images are representative of
three independent experiments.
(legend continued on next page)
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Dillon, 2007; von Rosenvinge et al., 2013), we also asked
whether this acceleration also occurred with eukaryotic DNA.
We used salmon sperm DNA and found that it also accelerated
curli polymerization by shortening the time in lag phase of poly-
merization by an average of 155 min (Figures 2F and 2G). These
findings suggest a mechanism by which DNA provides structural
stability to biofilms, by complexing with amyloids and promoting
their polymerization. Furthermore, the fact that eukaryotic DNA
also enhanced amyloid polymerization suggests that bacteria
could incorporate eukaryotic DNA (e.g., released during tissue
damage) into its biofilm structure. This process may generate
highly immunogenic molecules because both amyloids and
DNA can activate innate immune receptors (Hemmi et al.,
2000; Tu¨kel et al., 2009).
Curli-DNAComposites AreMajor Immune Stimulators in
S. Typhimurium Biofilms
Interactions of bacterial biofilms with the immune system are
poorly characterized. Here, we sought to elucidate these inter-
actions using an in vitro model of conventional dendritic cells
(cDCs), the pivotal initiators of the immune response that are
stimulated via pattern recognition receptors (PRRs) (Gallo
and Gallucci, 2013; Iwasaki and Medzhitov, 2004). We incu-
bated bone marrow-derived dendritic cells, expressing GFP,
on S. Typhimurium biofilms. Biofilms were allowed to mature
for 72 hr prior to addition of cDCs. The cDCs appeared to
send dendrites into the biofilm (Figures 3A, S3A, and S3B)
and phagocytose bacteria (Movies S1 and S2). Moreover,
cDCs produced high amounts of proinflammatory cytokines
including IL-6 and TNF-a (Figure 3B). These results indicate
that cDCs can uptake antigens and be activated by the imper-
vious bacterial biofilm.
Lipid A and monomers of S. Typhimurium flagella are well-
known immune activators that trigger TLR4-MD2-CD14 and
TLR5, respectively (Gewirtz et al., 2001; Takeuchi et al., 1999).
To determine the importance of LPS and flagellin in the stimula-
tory effect of biofilms, we established biofilms with a S. Typhi-
murium msbB mutant that expresses a tetra-acylated form of
lipid A, which does not signal through the TLR4-MD2-CD14,
and with a S. Typhimurium fliCfljB mutant that lacks flagella. Af-
ter 48 hr, the biofilms formed by the mutant bacteria were com-
parable to the biofilms formed by wild-type S. Typhimurium.
(Figures 3C and S3C). When cDCs were exposed to the bio-
films, cDCs produced equally high amounts of IL-6 in response
to the biofilms formed by wild-type S. Typhimurium, msbB mu-
tants, and fliCfljBmutants (Figure 3B). Although there was a sta-
tistically significant difference in the amount of TNFa produced
by cDCs in response to the msbB mutant biofilm when
compared to the wild-type S. Typhimurium and the fliCfljB
mutant biofilms, cDCs still produced high amounts of TNFa in(D) Microscopy of purified curli amyloids stained with CR and visualized under po
33258 (right panel) and visualized under fluorescent microscope.
(E) Microscopy of purified curli fibers costained with Hoescht 33258 (left panel) a
(F) Calculated polymerization lag times of synthetic peptides consisting of the am
presence of increasing concentrations of CpG (left), genomic DNA from Salmone
(G) Representative ThT amyloid polymerization assay curves for the polymeriza
genomic (middle), and salmon sperm (right) DNA. Three independent experimen
experiment. *p < 0.05; **p < 0.01; ***p < 0.001.response to the three biofilms (Figure 3B). Thus, although
LPS and flagellin are important for the interaction of immune
cells with planktonic S. Typhimurium, components other than
LPS and flagellin exist in the S. Typhimurium biofilm that
activate DCs.
Next, we sought to determine whether curli-DNA composites
are involved in DC response to curli-containing biofilms. How-
ever, since a curli-deficient S. Typhimurium does not form
biofilms (Figure S1B), we treated cDCs with a dose titration of
purified curli fibers. To avoid contamination with LPS, we purified
curli fibers from themsbBmutant and found that even nanogram
quantities of curli induced significant amounts of IL-6 and IL-12
in cDCs. Interestingly, curli was very potent in inducing the
Th1 cell-promoting cytokine IL-12 even when compared to the
dose of LPS that showed the maximal cytokine response in
cDCs (Figure 3D).
To determine the role of DNA in the stimulatory activity of curli-
DNA composites from biofilms, we attempted to remove the
DNA from the purified curli and found that we could not unless
we dissociated curli into its monomers. However, this treatment
damaged the DNA (Figure S2). To overcome this pitfall, we stim-
ulated cDCswith the synthetic CsgAR4-5 peptide polymerized in
the presence or absence of bacterial genomic DNA. DNA alone
and CsgAR4-5 polymerized in the absence of genomic bacterial
DNA induced minimal IL-6 and IL-12 production by cDCs. How-
ever, CsgAR4-5 polymerized in the presence of bacterial DNA
induced significant amounts of IL-6 and IL-12, suggesting that
curli and DNA synergize to activate innate immune cells (Fig-
ure 3E). The fact that the CsgAR4-5-DNA composites elicited
much lower amounts of cytokines than the purified curli suggests
that the natural aggregation of full-length curli may be required
for its full activity.
Curli-DNA Composites Stimulate the Type I Interferon
Response
Type I interferons (IFNs) are important stimulators of the innate
and adaptive immune response and are pathogenic in SLE
(Elkon and Stone, 2011). Type I IFNs can activate dendritic cells
as an exogenous stimulus (Gallucci et al., 1999) and they
mediate PRR-dependent activation of DCs through an auto-
crine feedback (Hoebe et al., 2003). Here, we tested whether
the curli-DNA composites purified from S. Typhimurium msbB
biofilms stimulate DC activation and found that curli-DNA com-
posites were potent inducers of type I IFNs and IFN stimulated
genes (ISGs) in vitro in cDCs from lupus-prone NZBxW/F1 and
non-lupus prone C57BL/6 mice (Figures 4A and 4B). Further-
more, in vivo injection of curli-DNA composites also resulted
in the upregulation of the ISGs Isg15 and Irf7 in splenic DCs
from young prediseased NZBxW/F1 lupus-prone mice (Fig-
ure 4C). These results indicate that curli-DNA composites arelarized microscope (left panel), propodium iodide (center panel), and Hoescht
nd ThT (center panel) and merged (right panel).
ino acid sequence of the fourth and fifth repeats of CsgA (CsgA R4-5) in the
lla (middle), and salmon sperm DNA (right).
tion of the CsgA R4-5 in the presence and absence of CpG (left), Salmonella
ts were completed with duplicate wells for each concentration of DNA in each
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Figure 3. Curli-DNA Composites Are
Danger Signals that Activate Dendritic Cells
(A) GFP-expressing cDCs (green) interact with S.
Typhimurium biofilms stained with CR (red). Image
shown is representative of three independent
experiments.
(B) Cytokine production by cDCs incubated for 6 hr
on 72 hr preformed biofilms from wild-type,msbB,
and DfliCfljB Salmonella.
(C) 3D reconstructions of CLSM images of GFP-
expressing WT (left panel), msbB (center panel),
and DfliCfljB (right panel) Salmonella biofilms
showing equivalent growth of these biofilms in
these conditions.
(D) Proinflammatory cytokine production from
cDCs stimulated with a dose titration of curli-
DNA composites isolated from Salmonella
msbB mutant biofilms. Cytokine production was
compared to LPS stimulation (100 ng/ml). Data in
(B)–(D) is representative of three independent
experiments, performed with three independent
bone marrow-derived cultures from 3 different
mice and each contained quadruplicate wells for
each bacterial strain.
(E) Synthetic amyloid peptide CsgA R4-5 was
polymerized in the presence or absence of Sal-
monella genomic DNA and used to stimulate
cDCs. Cytokine production in response to 20 mg/
ml CsgA R4-5, 20 ng/ml genomic DNA, or 20 mg/ml
CsgA R4-5 fibrillized in the presence of 20 ng/ml
genomic DNA is shown as average and SEM, n = 5.
*p < 0.05; **p < 0.01; ***p < 0.001.potent danger signals that stimulate autoimmune-prone innate
immune cells and may trigger autoimmunity by providing an
adjuvant effect through the stimulation of the pathogenic IFN
response.
Curli-DNA Composites Promote Autoimmunity
Next, we asked whether the naturally occurring curli-DNA com-
posites found in bacterial biofilms could induce autoimmunity in
the absence of any added adjuvant. Because we found that
curli-DNA composites stimulate the production of type I IFNs
(Figure 4), which accelerate disease onset in lupus-prone mice
(Mathian et al., 2005), we hypothesized that exposure to curli-
DNA composites may accelerate autoimmunity. We therefore in-
jected 6-week-old, prediseased, NZBxW/F1 mice i.p. with PBS
or 50 mg of curli-DNA composites once a week or three times a
week and monitored autoantibody production. Mice injected
with PBS remained negative for autoantibodies up to 20 weeks
of age. Mice injected with curli-DNA composites rapidly pro-
duced anti-dsDNA and anti-chromatin autoantibodies, a hall-
mark of lupus autoimmunity (Figure 5A). As a protein control,
we injected 50 mg of BSA i.p. into NZBxW/F1 age- and gender-
matched mice and found that injections with BSA did not induce1176 Immunity 42, 1171–1184, June 16, 2015 ª2015 Elsevier Inc.development of autoantibodies (Fig-
ure S4), suggesting specificity for the
autoimmunogenicity of curli.
Other adjuvants, including TLR li-
gands, can accelerate murine lupus
(Hang et al., 1983; Jørgensen et al.,2006). However, curli-DNA composites induce autoantibody
production very quickly and consistently, with all mice
becoming positive for anti-dsDNA within 2 weeks of the first in-
jection. We confirmed lupus autoimmunity in curli-DNA treated
mice by antinuclear antibody test (ANA). Curli-DNA treated
mice became ANA positive (Figure 5B), with an initial perinu-
clear-ER staining pattern; this pattern then evolved into a nu-
clear staining pattern by 15 weeks of age, resembling the
pattern expressed by aged, diseased Sle1,2,3 mice, another
strain of mice that spontaneously develop lupus (Morel et al.,
1997). Furthermore, when we injected curli-DNA composites
into SvJ-129 mice, which do not develop lupus spontaneously
but are genetically predisposed to autoimmunity (Bygrave et al.,
2004), we found that these mice rapidly produced both anti-
dsDNA and anti-chromatin autoantibodies (Figure S5), confirm-
ing that bacterial amyloid-DNA composites are sufficient to
trigger autoimmunity.
We next analyzed the subclasses of autoantibodies that are
induced by curli-DNA composites. We found that anti-dsDNA
and anti-chromatin autoantibodies were mostly of immunoglob-
ulin G (IgG) subclass 2a and 2b, as in diseased Sle1,2,3 lupus-
prone mice (Figures 5C and 5D). Since IgG2a and IgG2b
AB
C
Figure 4. Curli-DNA Composites Elicit Strong Type I Interferon Responses from cDCs In Vitro
(A and B) mRNA expression of interferon beta, Ifnb, and two IFN-stimulated genes (ISGs), Irf7 and Isg15, from cDCs generated in vitro for 6–7 days from bone
marrow of NZBxW/F1 mice (A) and C57BL/6 mice (B) and stimulated for 6 hr with curli/DNA composites isolated from Salmonella biofilms. All of the conditions
were normalized against the control (untreated DCs inmedium only) for each strain in each experiment. Results are an average of three independent experiments.
(C) ISG mRNA expression in NZBxW/F1 splenic CD11c+ DCs isolated by magnetic beads 20 hr post i.p. injection of 50 mg of curli. *p < 0.05.subclasses are generally considered pathogenic in systemic
autoimmunity (Clynes et al., 1998; Ehlers et al., 2006), our results
indicate that curli-DNA composites promote the production of
pathogenic autoantibodies.
Curli-DNA Composites Induce Autoimmunity in
Wild-Type Mice
To test whether naturally occurring curli-DNA composites induce
autoimmunity inmice not prone to lupus, we injected B6mice i.p.
with curli (50 mg per injection) three times a week and found anti-
dsDNA and anti-chromatin autoantibodies as soon as 2 weeks
after injection (Figure 6A), following the same kinetics seen in
NZBxW/F1 and SvJ-129 mice. These results indicate that the
direct exposure of the immune system to the danger signal
curli-DNA composites is sufficient to break self-tolerance in non-
autoimmune mice.
To investigate the effects of curli-DNA composites on adap-
tive immune cells in vivo, we injected mice i.p. with either
50 mg of curli-DNA composites or PBS and analyzed markers
of activation in splenic populations 24 hr later. Injection of
curli-DNA composites upregulated the expression of the cos-
timulatory molecule CD86 on CD19+ B cells and the activation
marker CD69 on both CD4+ and CD8+ T cells (Figure 6B),suggesting that curli-DNA composites stimulate polyclonal
activation of T and B cells. It also caused an increase of
CD11b+Ly6C+ inflammatory myeloid cells in the spleen (Fig-
ure S6). Moreover, curli-DNA composite injection induced
DC activation in vivo, as splenic CD11c+ DCs upregulated
both costimulatory molecules CD86 and CD80 (Figure 6C)
and highly expressed the ISGs Irf7 and Isg15 (Figure 6D).
Thus, bacterial amyloids, and in particular the curli-DNA com-
posites, represent a class of danger signals that stimulate
innate immune cells and induce polyclonal activation of adap-
tive immunity.
Infection with Curli-Competent Bacteria Accelerates
Autoimmunity
We next asked whether curli-expressing bacteria, either
commensal or pathogenic, promote autoimmunity in lupus-
prone NZBxW/F1 mice. We injected young prediseased
NZBxW/F1 mice i.p. with either wild-type (curli-expressing) or
curli mutant commensal E. coli or virulent S. Typhimurium. Sys-
temic route of infection (i.p.) was chosen to mimic the propensity
of SLE patients to develop systemic infections including bacter-
emia. We injected E. coli once aweek for 4 weeks or S. Typhimu-
rium once every 2 weeks for 8 weeks. We spaced SalmonellaImmunity 42, 1171–1184, June 16, 2015 ª2015 Elsevier Inc. 1177
Figure 5. Curli/DNA Composites Accelerate Systemic Autoimmunity in Lupus-Prone NZBxW/F1 Mice
(A) Anti-dsDNA and anti-chromatin autoantibodies weremeasured by ELISA in sera fromNZBxW/F1mice injectedwith PBS thrice aweek, curli once a week (13), or
curli thriceaweek (33).Opticaldensity (O.D.) indicatesELISAcolorchangeand thepresenceofanti-dsDNAoranti-chromatinautoantibodies.Errorbars indicateSEM,
n = 5 per group. The dotted horizontal line indicates cutoff for positivity, calculated as two standard deviations above the average of sera from naive C57BL/6 mice.
(B–D) Representative antinuclear antibody assay (ANA) of sera from mice as in Figure 5A at the indicated ages (B). Hep-2 cells were incubated with sera and
FITC-conjugated anti-IgG Abs. Antibody isotype determinations of anti-chromatin (C) and anti-dsDNA (D) antibodies. Serum from 10 month-old-diseased
Sle1,2,3 mouse was utilized as positive control and from naive C57BL/6 mouse was used as negative control. *p < 0.05.
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Figure 6. Curli/DNA Composites Induce
Autoantibody Production and Immune Cell
Activation in WT Mice
(A) Anti-dsDNA and anti-chromatin autoantibody
ELISAs from C57BL/6 mice injected with PBS or
curli thrice a week (3x). As in Figure 5, optical
density (O.D.) indicates ELISA color change and
the presence of anti-dsDNA or anti-chromatin.
Error bars indicate SEM, n = 5 per group.
(B and C) Flow cytometry analysis of the expres-
sion of activation markers in T cells and B cells (B)
and in DCs (C) from spleens of C57BL/6 mice 20 hr
post i.p. curli injection.
(D) mRNA expression of two interferon-stimulated
genes (ISGs), Irf7 and Isg15, from C57BL/6 splenic
CD11c+ DCs isolated with magnetic beads from
the samemice. Results are shown as averages and
standard deviation, n = 3 per group, *p < 0.05.injections every 2 weeks to prevent mouse death. We then
stopped injections and let mice recover for at least 4 weeks.
We found that mice infected with curli-competent bacteria,
both E. coli and Salmonella, developed high titers of autoanti-
bodies (Figures 7A and 7B), similar to those induced by isolated
curli-DNA composites (Figure 5). Mice exposed to curli-deficient
bacteria also developed autoantibody titers, albeit at lower
amounts compared to curli-competent strains. This could be
due to other danger signals expressed by the bacteria such as
LPS, which was previously shown to trigger autoantibody pro-
duction in mice (Fournie´ et al., 1974). The fact that higher
amounts of autoantibodies were produced upon infections
with curli-competent bacteria indicates that curli is a major auto-
immunogen in these bacteria (Figures 7A and 7B). The predom-
inant autoantibody isotype in response to infection was IgG2a,
and IgG2b and IgG3 were also positive to a lesser extent (Fig-
ure 7C), suggesting that infection promotes the production of
pathogenic autoantibodies to nuclear antigens. Furthermore,
mice infected with curli-competent wild-type bacteria had signif-
icantly stronger ANA staining (Figure 7D). Interestingly, sera from
mice infected with S. Typhimurium showed both nuclear and
cytoplasmic staining, while mice infected with E. coli showed nu-
clear staining only, suggesting that different bacteria may diver-
sify the autoantibody repertoire. After sacrificing the animals, we
analyzed blood, spleens, and livers for colony forming units
(CFUs) and found no evidence of persistent infection at the
time of euthanasia (data not shown). Taken together, our results
indicate that the exposure to curli or infection with biofilm-
competent bacteria promotes the development of autoanti-
bodies in susceptible mice.Immunity 42, 1171–118DISCUSSION
Studies using amyloid specific dyes
demonstrated that up to 40% of the bac-
terial biofilms contain amyloids (Larsen
et al., 2007). However, it has been a chal-
lenge to identify novel bacterial amyloid
proteins using basic amino acid alignment
searches because these proteins do not
share any sequence homology but theyhave a common quaternary structure. Although curli fibers
were initially thought to be encoded by only the members of
the Enterobactericeae family, gene homologs encoding curli
were recently determined also in four phyla: Bacteroidetes, Pro-
teobacteria, Firmicutes, and Thermodesulfobacteria (Dueholm
et al., 2012; Hufnagel et al., 2013). Among these, Bacteriodetes,
Firmicutes, and Proteobacteria are the major phyla found in the
gastrointestinal tract, but more work is needed to determine
the abundance of amyloids in the gastrointestinal tract (Gill
et al., 2006; Hooper et al., 2002; Turnbaugh et al., 2007). Besides
curli fibers, amyloids are produced also by Staphylococcus
aureus and Mycobacterium tuberculosis (Alteri et al., 2007;
Chapman et al., 2002; Hufnagel et al., 2013; Schwartz et al.,
2012).
Although it was known that amyloids and DNA are incorpo-
rated into the biofilm ECM (Whitchurch et al., 2002), little is
known about their interactions. Here, we demonstrate that
DNA released during biofilm formation is incorporated into curli
fibers of S. Typhimurium and accelerates the fiber polymeriza-
tion process. Because we found that only approximately 10%
of the bacteria die in the biofilm population, the high number of
live bacteria with a red DNA corona around them point to an
active nucleic acid extrusion mechanism during S. Typhimurium
biofilm development. Furthermore, the hollow areas lacking
green bacteria but showing only the red amyloid stain suggest
that in order to incorporate into curli fibers, eDNA must
be present during the initial stages of amyloid production and
polymerization.
Our resultsusingeukaryoticDNA fromsalmonspermalsoshow
that eukaryotic DNA can be incorporated into bacterial amyloid4, June 16, 2015 ª2015 Elsevier Inc. 1179
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Figure 7. Infection with Curli-Producing Bacteria Accelerates Autoimmunity in Lupus-Prone Mice
Anti-dsDNA and anti-chromatin autoantibody ELISAs from NZBxW/F1 mice injected with live E. coli or S. Typhimurium strains.
(A) Wild-type E. coli or its csgA mutant was injected i.p. into NZBxW/F1 mice at 105 CFU for four times.
(B) Live virulent S. Typhimurium or its isogenic csgBA mutant was injected i.p. into NZBxW/F1 mice at 105 CFU for four times.
(C) Autoantibody isotypes; the dotted horizontal line indicates cutoff for positivity, calculated as two standard deviations above the average of sera from naive
C57BL/6 mice. *p < 0.05.
(D) Two representative ANA stainings from each experimental group are shown. Magnified insets are in the right corners of two pictures.fibers, which suggest that host DNA, released in the vicinity of a
bacterial biofilm possibly during tissue damage, may be incorpo-
rated into the ECM through this mechanism. Moreover, neutro-
phils extrude largeamountsofDNAcalled theneutrophil extracel-
lular traps (NETs) asamechanismtokill bacteria (Brinkmannet al.,1180 Immunity 42, 1171–1184, June 16, 2015 ª2015 Elsevier Inc.2004). Recent studies have shown that P. aeruginosa can incor-
porate neutrophil-derived DNA into its ECM in order to form a
thicker biofilm (Walker et al., 2005). Together with our results,
these findings suggest that bacteria may take advantage of eu-
karyotic DNA in the vicinity to enhance its ECM.
DCs are the sentinels of the immune system, which recognize
pathogen-associated molecular patterns (PAMPs) (Iwasaki and
Medzhitov, 2004) and damage-associated molecular patterns
(DAMPs) (Gallo and Gallucci, 2013) during infection or tissue
damage and initiate the adaptive immune response (Merad
et al., 2013). We found that DCs are highly activated by biofilms
and by curli-DNA composites in particular. We have also re-
ported that the amyloid component of curli fibers stimulates
the macrophages through the TLR2-TLR1 complex (Rapsinski
et al., 2013; Tu¨kel et al., 2010). These results indicate that curli
fibers are PAMPs, able to stimulate the innate immune system.
Although studies on eDNA and its sensors are limited, bacterial
dsDNA can stimulate TLR9 (Hemmi et al., 2000) and cytosolic
STING-dependent DNA sensors, resulting in a type I interferon
response (Ishikawa et al., 2009). The fact that curli-DNA com-
posites are more immunostimulatory than curli or DNA alone
suggests that different immune receptors might synergize to
recognize these novel molecular patterns in bacterial biofilms.
As many other PAMPs, curli-DNA composites strongly induce
the expression of type I IFNs and the IFN-stimulated response in
DCs in vitro and in vivo. A type I IFN signature is upregulated in
PBMCs of SLE patients (Baechler et al., 2003; Bennett et al.,
2003; Crow et al., 2003; Feng et al., 2006; Han et al., 2003)
and in DCs from lupus-prone mice (Sriram et al., 2012), and
administration of exogenous type I IFNs accelerates autoimmu-
nity in lupus-prone mice (Mathian et al., 2005). Therefore, the re-
sults that curli-DNA composites accelerate the onset of autoim-
munity in lupus-prone mice can be partially explained by the
strong induction of type I IFNs in DCs as well as by the polyclonal
activation of the adaptive immune system, as curli upregulated
activation markers in splenic T and B cells.
SLE manifests with the production of antinuclear antibodies,
including those directed against DNA, ribonucleoprotein com-
plex (RNP), and nucleosomes (Tan, 2012). Our findings that
naturally occurring bacterial curli-DNA composites, which can
contain both bacterial and eukaryotic DNA, efficiently trigger
type I IFN stimulation and autoantibody production point to a
unique bacterial stimulator of autoimmunity. The fact that eu-
karyotic DNA complexes with the bacterial amyloid curli brings
up the possibility of the exposure of the lupus-prone immune
system to autoAgs by the curli-DNA composites in the presence
of the adjuvant effects caused by TLR triggering and type I IFN
stimulation. Self-Ags can be released by NETs or by necrotic
cells during tissue damage induced by bacterial infections.
Moreover, defects in phagocytosis and clearance of apoptotic
cells are associated with lupus (Nagata et al., 2010) and may
allow self-DNA from postapoptotic cells to be incorporated
into biofilms and become immunogenic.
SLE has a multifactorial pathogenesis in which the genetic
make-up and environmental triggers are considered the major
players (Liu and Davidson, 2012). Among the environmental trig-
gers, infections have been proposed as either the initiators of
autoimmunity or the triggers of flares, the sudden increase in dis-
ease severity (Petri, 1998). Several studies have tested this hy-
pothesis, providing conflicting results; for example, lupus-prone
MRL/lpr mice bred in germ-free conditions develop lupus-like
disease (Maldonado et al., 1999), suggesting that genetics trump
environmental factors. However, the fact that SLE has a concor-
dance of 30%–40% in identical twins (Connolly andHakonarson,2012), clearly indicate that the environmental triggers are
required in human disease. Consistent with the idea that bacte-
rial infections contribute to lupus pathogenesis, we found that
infection with biofilm-competent, curli-producing bacteria exac-
erbates autoimmunity in lupus-prone mice. These results are
possibly due to the direct exposure to curli itself but also to the
fact that curli-expressing bacteria are better protected from
the immune response—thereby increasing exposure and
causing a greater immune activation.
How bacterial infections contribute to lupus pathogenesis and
flares remains inconclusive. Our study suggests that biofilm-
derived curli-DNA composites can accelerate autoimmunity
through the induction of type I IFNs, the activation of DCs, and
the polyclonal stimulation of T and B cells. The fact that also
the commensal strain of E. coli could accelerate autoimmunity,
and that Salmonella and E.coli induced different patterns of au-
toantibodies, highlights the need to address how the interaction
with pathogens and microbiota affects autoimmunity in geneti-
cally susceptible individuals.
Our results—that curli-DNA composites can trigger autoim-
munity even in nonautoimmune-prone mice—raise the question
of why autoimmunity is not more frequent in the human popula-
tion that is often exposed to biofilm-forming bacteria. A working
hypothesis is that in non-lupus-prone individuals, or murine
strains, natural infections do not normally result in the systemic
release of curli-DNA composites in amounts equivalent to those
we injected in this study; while in susceptible individuals, genet-
ically determined dysfunctions may increase the systemic expo-
sure to curli-DNA composites during chronic infections. The
more frequent outcome of Salmonella infection in bacteremia
and complications in soft tissues in SLE patients (Lim et al.,
2001; Pablos et al., 1994; Tsao et al., 2002), and the recent iden-
tification of increased levels of circulating endotoxin in SLE
patients (Shi et al., 2014), support this hypothesis. In addition,
because inflammatory cytokines can decrease intestinal
mucosal barrier function (Turner, 2009), the high levels of cyto-
kines present in predisease stages of lupus (Connolly and Hako-
narson, 2012; Sriram et al., 2012) might compromise mucosal
barrier function and allow the biofilm material produced by mi-
crobiota at mucosal sites to access the immune system, act as
a danger signal, and trigger lupus onset.
Our study highlights a role of bacterial amyloid-DNA compos-
ites in stimulating the innate and the adaptive immune system
and suggests that chronic biofilm-producing bacterial infections
may represent an important environmental contributor to SLE
pathogenesis.EXPERIMENTAL PROCEDURES
Bacterial Strains
S. Typhimurium strain IR715 is a fully virulent, nalidixic acid-resistant strain
derived from the ATCC strain 14028 (Stojiljkovic et al., 1995). An unmarked
deletion of csgBA mutant of S. Typhiumurium strain 14028 (Nishimori et al.,
2012), S. Typhimurium EHW26, a fliCfljB mutant, and S. Typhimurium RPW3
that contains a mutation in msbB were previously described (Raffatellu et al.,
2005). E. coli Nissle 1917 was first described by Alfred Nissle (Nissle, 1957).
Biofilms and CLSM
Bacterial strainswere grown in LBno-saltmedia at 30C to promote biofilm for-
mation. DNA was visualized in biofilms by staining with 1 mg/ml propidiumImmunity 42, 1171–1184, June 16, 2015 ª2015 Elsevier Inc. 1181
iodide (Molecular Probes), 1 mg/ml Hoescht 33258, or 1 mg/ml TOTO-1 (Life
Technologies). Curli fibers were stained with 10 mM Thioflavin T or 10 mg/ml
CR and visualized with a Leica SP5 microscope with a TCS confocal system.
For confocal laser scanning microscopy (CLSM) imaging of dendritic cells on
biofilms, biofilms were grown in an 8-chamber microscope coverslip (Nunc)
at an angle to allow for the formation of pellicle biofilm on the coverslip. After
72 hr, media was removed and GFP-expressing, bone marrow-derived den-
dritic cells generated from C57BL/6-Tg(CAGEGFP)131Osb/LeySopJ mice,
kindly provided by Dr. Doina Ganea (Temple University, Philadelphia, PA)
were placed on the biofilms. CLSM images of biofilm of wild-type S. Typhi-
murium containing a plasmid vector for constitutive expression of the red
fluorescent protein d-Tomato, kindly provided by Dr. Yao-hui Sun at UC Da-
vis. Crystal violet assay was performed as described previously (Crawford
et al., 2008)
Acceleration of lupus onset
NZBxW/F1 mice were purchased from Jackson Laboratories. C57BL/6 (B6),
congenic Sle1,2,3, and 129/SvJ mice were purchased from Jackson Labora-
tories and bred and maintained in our colonies in accordance with the
guidelines of the Institutional Animal Care and Use Committees of Temple Uni-
versity, a member of the American Association for the Accreditation of Labo-
ratory Animal Care. Six-week-old female NZBxW/F1 mice and B6 and 129
mice were injected i.p. with PBS, or 50mg curli-DNA composites or BSA in
0.5 ml PBS either once a week or three times a week. Serum was collected
to monitor autoantibody production.
Lupus and Infections
E. coli and S. Typhimurium were grown in biofilm-promoting conditions. Live
wild-type E. coli or its csgA mutant was injected i.p. into 8-week-old female
NZBxW/F1mice at 105 CFU per injection once a week for 4 weeks (4 injections
total). Live S. Typhimurium or its isogenic csgBA mutant was injected i.p. into
age-matched female NZBxW/F1 mice at 104 CFU per injection about once
every 2 weeks for 8 weeks (4 injections total). Mice were allowed to recover
from infection for 4 and 8 weeks after the last injection (for S. Typhimurium
and E. coli, respectively).
The rest of the Experimental Procedures are in the Supplemental
Information.
Statistical Analysis
Data were analyzed using Prism software (GraphPad). One-sample t test or
two-tailed Student’s t test were used as appropriate. A p value of < 0.05
was considered significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, Supplemental Experimental
Procedures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2015.06.002.
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